Fibrinolytic agents.
D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010447:Peptide Hydrolases / Q000494:pharmacology; D010958:Plasminogen / Q000032:analysis; D010960:Plasminogen Activators / Q000494:pharmacology; D011655:Pulmonary Embolism / Q000188:drug therapy; D013300:Streptokinase / Q000494:pharmacology; D013924:Thrombophlebitis / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D005343:Fibrinolytic Agents; D010958:Plasminogen; D010447:Peptide Hydrolases; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator